Ultrastructural studies of neurofibrillary tangles in Alzheimer disease (AD) have demonstrated a close relationship between nuclear pores and the cytoplasmic paired helical filaments comprising the tangles, as well as nuclear irregularity in many tangle-bearing neurons; nuclear pore aggregation has been observed in nearby neurons. These observations prompted examination of the nuclear pore complex (NPC) and proteins critical to nucleocytoplasmic transport in neurons with and without tangles in AD and control cases. Light microscopic study of hippocampus and neocortex in AD and controls revealed that all nuclei were labeled by antibodies to NPC proteins, including the central transporter nucleoporin Nup62. Nucleoporin and tau label revealed significantly more nuclear irregularity in AD, often associated with neurofibrillary tangles. Double label of Nup62 with apoptotic markers (TUNEL and active caspase-3) and a cellcycle protein (cyclin B1) revealed no clear relationship of nuclear irregularity to apoptosis or cell-cycle protein expression. However, cytoplasmic accumulation of nuclear transport factor 2 (NTF2), a protein that transports cargo from the cytoplasm into the nucleus, was observed in a subset of hippocampal neurons with and without tangles in AD but not control cases. Further investigation of the NPC and nucleocytoplasmic transport in AD is warranted.
INTRODUCTION
Electron microscopic studies of ''early'' neurofibrillary tangle (NFT)-bearing neurons in Alzheimer disease (AD) biopsy material have revealed the proximity of paired helical filaments (PHF) to the nuclear envelope and nuclear pore complex (NPC), striking nuclear irregularity in many neurons, as well as aggregation of nuclear pores in adjacent neurons without apparent PHF (1, 2) . These observations, coupled with emerging knowledge concerning the central role of NPC in bidirectional nucleocytoplasmic transport, prompted us to investigate the potential involvement of the NPC in AD. We hypothesized that changes in the NPC may lead to dysfunction in nucleocytoplasmic transport and contribute to abnormal filamentous aggregates in AD.
In vertebrates, the NPC is a 60-to 125-MDa structure spanning the nuclear envelope and is composed of approximately 30 distinct structural proteins (nucleoporins). Large macromolecules are actively transported through its central transporter, whereas small molecules may diffuse through one of the 8 channels in the symmetric spoke-ring complex ( Fig. 1) . At least 18 NPC-associated proteins (e.g. transportins such as nuclear transport factor 2 [NTF2], importins, exportins, and karyopherins) have been identified, most of which are required for nucleocytoplasmic transport of large molecules through multiple pathways (3) (4) (5) (6) . Conceivably, alterations to the structure or number of NPC or changes in regulation of nucleocytoplasmic transport could impact cell viability or key cellular functions, including transcription, translation, and protein synthesis.
Only recently has the NPC been studied in human disease such as autoimmune, neoplastic, viral, and genetic disorders (for review, [7] ). Nucleoporin Nup88 overexpression occurred in certain fetal tissues as well as numerous malignant neoplasms, including carcinomas, malignant mesotheliomas, sarcomas, and glioblastoma multiforme (8) (9) (10) ; normal adult tissues and most benign processes show little or no reaction to Nup88 antisera outside of the typical nuclear location. Nup214, previously known as the CAN protein, a putative oncogene product, is associated with myeloid leukemogenesis (11) . Additionally, triple A syndrome (Allgrove syndrome) has been attributed to mutations in the gene encoding the NPC protein, ALADIN (12) . Manifestations of this autosomalrecessive disorder include hyperreflexia, muscle wasting, dysarthria, ataxia, optic atrophy, and intellectual impairment (13) . Finally, a case of X-linked mental retardation has been associated with disruption of the gene encoding an NPCassociated nuclear RNA export protein (14) . The authors cautioned that this genetic change may not have directly caused the mental retardation, although it may have affected brain development.
Changes in the NPC also have been observed with apoptosis in vitro. These include migration of nuclear pores to areas of diffuse chromatin, sequential degradation of nucleoporins, nuclear contour irregularity, and nuclear pore clustering (15) (16) (17) . Although apoptosis is required for central nervous system development, its role in AD and neurodegenerative diseases has been controversial (18) (19) (20) (21) (22) . Markers of the apoptotic pathway are expressed in AD, including fragmented DNA (as shown by TUNEL-positive label) (23, 24) , caspase-3 (25) (26) (27) , and caspase-9 (28).
Cell division constitutes yet another process in which the NPC and nuclear envelope undergo dramatic changes in a sequential manner. During mitosis, the nuclear envelope breaks down and the NPCs disassemble into small subunits. For NPC rebuilding, the nuclear envelope forms followed by sequential reassembly of the NPC proteins (29) (30) (31) . Although it is presumed that terminally differentiated neurons cannot reenter the cell cycle, expression of cell-cycle proteins has been reported in neurodegenerative disorders, including AD (for review, [32, 33] ).
Remarkably few studies of the NPC in normal or abnormal central nervous system have been reported. In rat brain, the number of NPCs per unit length of nuclear envelope and the diameter of NPCs reportedly remained stable with age in CA1 pyramidal neurons but decreased in dentate gyrus granular cells (34, 35) . In rat cerebellar cortex, the density of nuclear pores per unit of nuclear envelope differed among cell types, with Purkinje cells having the highest and oligodendrocytes the lowest density (36) . More recently, in a study of rat brain, nucleoporin p62 (Nup62) was found at the nuclear rim as well as the interior of neuronal nuclei (37) . To our knowledge, the NPC has not been investigated in AD with the exception of the electron microscopic studies cited previously (1, 2) .
In the present immunohistochemical study, we examined the distribution of nucleoporins in AD using antibodies to several major nucleoporins. The relationship of these nucleoporins to apoptosis and the cell cycle also was investigated. We examined 2 apoptotic markers, TUNEL (an end-stage marker) and active caspase-3 (an enzyme involved in an earlier stage of apoptosis also implicated in the cleavage of both tau and amyloid precursor protein [28, 38, 39] ), as well as cyclin B1, an M-phase marker of the cell cycle found in AD neurons (40, 41) .
MATERIALS AND METHODS

Cases Studied Electron Microscopy
Ultrastructural study was performed on sections of tissue obtained from right frontal lobe cortical biopsies on 5 patients clinically and neuropathologically diagnosed as having AD. The biopsies had been undertaken during shunt placement for normal pressure hydrocephalus or as part of an experimental therapy involving intraventricular administration of bethanechol chloride (42) .
Light Microscopy
Sections (8-10 mm) of formalin-fixed, paraffin-embedded autopsy brain tissue from 10 AD cases were examined. The mean age at death for these AD cases was 80.6 years (range, 70-88 years). Not surprisingly, all of the AD cases exhibited frequent neurofibrillary tangles in CA1 of the hippocampus. In addition, autopsy brain tissue derived from 9 elderly individuals (mean age, 72.7 years; range, 65-96 years) and 3 middle-aged individuals (mean age, 52.7 years; range, 51-56 years) without clinical or neuropathologic evidence of neurologic disorder was examined.
Electron Microscopy
Cortical biopsy tissue was fixed in 0.2 N cacodylatebuffered 4% glutaraldehyde, postfixed in osmium tetroxide, dehydrated, and embedded in 812 Epon. After screening toluidine blue-stained thick sections, thin sections were cut, stained with uranyl acetate and lead citrate, and viewed and photographed on a transmission electron microscope.
Immunohistochemistry
Sections were immunohistochemically double-labeled using combinations of the antibodies listed (Table) . First, the sections were deparaffinized and rehydrated, and then pretreated using the method(s) that produced the optimal labeling for each antibody (Table) . A standard immunohistochemistry protocol was followed to obtain sequential labeling with 2 different primary antibodies. Briefly, the sections were FIGURE 1. Schematic diagram of the nuclear pore complex located within the nuclear envelope (NE) at the interface of cytoplasm (C) and nucleus (N) indicating the approximate location of the nucleoporins and NFT2 immunolabeled in this study. Large macromolecules are actively transported through the nuclear pore complex through the central transporter complex. Small molecules may diffuse through the channels of the spoke-ring complex located at the cytoplasmic and nucleoplasmic sides of the nuclear pore complex. For active transport, a RanGDP-RanGTP gradient is required across the nuclear envelope. NTF2 carries RanGDP through the central transporter complex, binding to Nup62 as the complex of NTF2-RanGDP travels into the nucleus (arrows with dotted lines). NTF2, nuclear transport factor 2 that transports cargo from cytoplasm to nucleus; RanGDP, Ras-related nuclear protein bound to guanosine diphosphate (transported by NTF2); Nup88 and Nup214, 2 nucleoporins that form a subcomplex within the cytoplasmic filaments of the nuclear pore complex. *, Nup62, nucleoporin p62, a component of the central transporter complex; Nup153, nucleoporin in the ring of the nuclear basket.
quenched with 3% hydrogen peroxide and preblocked in 10% normal serum. The tissue was incubated in the first primary antibody followed by the appropriate secondary antibody (Vector Laboratories, Burlingame, CA), ABC Elite kit (Vector Laboratories), and developed using diaminobenzidine (DAB; Sigma, St. Louis, MO) as the chromogen. After rinsing in buffer, the sections were preblocked a second time in 10% normal serum, and the same steps were used for the second primary antibody, ending with a contrasting blue-gray chromogen (Vector SG Substrate Kit for Peroxidase; Vector Laboratories). Finally, the sections were dehydrated and coverslipped with Cytoseal 60 (Richard-Allan Scientific, Kalamazoo, MI).
For fluorescent and confocal microscopy, the immunohistochemical procedure was the same with the exception of replacing the ABC Elite kit with fluorescent-tagged avidin D (Vector Laboratories). In addition, double-stranded DNA was fluorescently labeled using ToPro-3 (Molecular Probes, Inc., Eugene, OR) to aid in identifying the nuclei of individual cells.
Tunel
The ApopTag In Situ kit (Chemicon International, Inc., Temecula, CA) was used according to the manufacturer's instructions for the TUNEL method (terminal deoxytransferasemediated dUTP nick end labeling). To double-label with an antibody, Triton X-100 solution (1%; Sigma) was used to permeabalize the tissue. TUNEL-positive cells were visualized using DAB. Only cells with dense TUNEL labeling and a shrunken nuclear appearance were identified as apoptotic.
Assessment of Immunolabeling
Neurons were classified into those having regular or irregular nuclear contours as highlighted by Nup62 labeling. Nuclei were considered irregular if ruffled edges, invaginations, or extreme distortions were noted. On double-labeled sections, the presence or absence of immunoreactivity with a second primary antibody (tau or active caspase-3/PAb CM1) was assessed. In tau-positive cells, the reaction product assumed the typical configuration of NFT corresponding with NFT seen on silver stains of adjacent sections. Thus, the taupositive cells counted in this study were all tangle-bearing neurons. For the CA1 and CA4 regions of the hippocampus, neurons within a demarcated area approximately 700 3 750 mm were counted with regard to regular or irregular nuclear contour and presence or absence of tau (NFT) or active caspase-3/PAb CM1 labeling. The mean percentage of neurons for each category was obtained for the AD and elderly non-AD groups. For statistical analyses, the independent t-test was used to compare the extent of nuclear contour irregularity in AD and non-AD cases. For the AD cases, the dependent t-test was used to compare the extent of nuclear contour irregularity in neurons with and without NFT. In all statistical analyses, the level of significance was p , 0.05, and the values listed are mean percent of neurons positively labeled (6 standard error of mean). Finally, using immunohistochemistry, the relationship of active caspase-3 to tau and NTF2 to tau on hippocampal sections and cyclin B1 to Nup62 on temporal lobe sections were evaluated on AD and non-AD cases.
RESULTS
Electron Microscopic Findings
All 5 biopsy cases exhibited the typical fine structural changes of AD. NFT containing PHF and neuritic plaques displaying dystrophic neurites with PHF and dense bodies were found within cerebral cortex. Amyloid deposition within plaques and blood vessel walls was observed. The tanglebearing neurons often exhibited cytoplasm packed with PHF and frequently irregular nuclei. Other neurons evidenced ''early'' changes with relatively few PHF, usually in close apposition to the nuclear envelope and nuclear pores ( Fig. 2A) . In addition, neighboring neurons with markedly irregular nuclei and prominent clusters of nuclear pores admixed with microtubules and mitochondria were noted (Fig. 2B) .
Immunohistochemical Findings
Nucleoporin labeling by 3 antibodies (QE5, Nup88, and Nup62) outlined the nuclear envelope of all cell types within AD and control cases. Nup62 provided optimal labeling with low background. Using confocal imaging, a punctate pattern of NPCs on the nuclear envelope was clearly visible, highlighting the nuclear contour of each cell (Fig. 3) . Although immunoreactivity of QE5 antibody directed against 3 nucleoporins also was strong, Nup88 label was less prominent (data not shown).
The nuclear irregularity seen by electron microscopy was accentuated by nucleoporin immunohistochemistry (Fig. 4) . Nup62 labeling of CA1 revealed that the percentage of neurons displaying nuclear irregularity was nearly 10 times higher in AD than in elderly controls and nearly 4 times greater in AD CA4 neurons than in elderly controls (p , 0.0001 and p , 0.0001, respectively; Fig. 5A ). In both CA1 and CA4 regions in AD, nuclear irregularity was more common in tangle-bearing neurons than tau-negative neurons, although these differences did not reach statistical significance (p = 0.059 and p = 0.058, respectively; Fig. 5B ). Thus, the nuclear contour irregularity observed in the AD cases could not be solely attributed to NFT formation.
Our examination of apoptotic markers revealed no clear association with nuclear irregularity. Only scattered neurons in AD hippocampus and surrounding cortex were densely TUNEL-positive with shrunken nuclei (Fig. 6A, B) , whereas no neurons in the non-AD hippocampus were TUNELpositive. The 2 antibodies against active caspase-3 demonstrated different patterns of immunoreactivity within AD hippocampal neurons. Using PAb CM1 against active caspase-3 in the 6 AD cases, approximately 14% (68%) of CA1 and 11% (66%) of CA4 neurons with clear nucleoporin (Nup62) label were immunopositive (Fig. 6C, D) ; apoptotic bodies were consistently PAb CM1-positive. Over three fourths of the CM1-positive neurons in CA1 and CA4 displayed nuclear irregularity, as highlighted by Nup62 label. In the elderly non-AD cases (n = 7), only rare labeling by the PAb CM1 antibody was seen. However, using a second antibody to active caspase-3 (Promega) on hippocampus derived from AD (n = 6) and non-AD (n = 4) cases, no label was seen (data not shown). Although technical issues cannot be ruled out, the discrepancy in result may be related to differences in degradation of the epitopes recognized by each of these active caspase-3 antibodies. Indeed, Tawa et al demonstrated that the mature and active form of caspase-3 was rapidly degraded in vitro and that a synthetic inhibitor prevented degradation and blocked enzyme activity (43) . Nonetheless, the extent of nuclear irregularity in the AD cases was so much greater than the degree of apoptosis suggested by either the TUNEL method or the active caspase-3 label of PAb CM1 antibody that no direct association between nuclear irregularity and apoptosis can be inferred.
Similarly, we found no clear association between cellcycle protein expression and nuclear irregularity. Cortical neurons in AD superior temporal cortex generally showed less frequent nuclear irregularity than hippocampal neurons in the same cases. Variable labeling by cyclin B1 was observed in superior temporal cortex in neurons with no discernible relationship to nuclear contour (data not shown).
We also examined the distribution of NTF2, an NPCassociated protein essential for nucleocytoplasmic transport that interacts with the central transporter protein Nup62 (44) . NTF2 immunopositivity outlined the nuclear contour in all cell types in a manner similar to the nucleoporin label described previously. The relationship of NTF2 to neurofibrillary tangles as seen on tau immunohistochemistry was assessed in 5 AD and 3 control cases. In 4 of the 5 AD cases, several CA1 neurons exhibited prominent juxtanuclear accumulation of NTF2 (Fig. 7) regardless of the presence or absence of tangles. Although the significance of this observation is uncertain, this aggregation of NTF2 may reflect alteration in nucleocytoplasmic transport.
Additional Findings
We also found that other neuropathologic features of AD (i.e. neuritic plaques, Hirano bodies, and granulovacuolar degeneration) were labeled by antibodies to either or both nucleoporins and active caspase-3 (Fig. 8) . Moderate numbers of neuritic plaques exhibited immunopositivity for QE5 (the antibody recognizing 3 nucleoporins; Fig. 8A ). Although colocalization with tau was not observed, remnants of nuclear material sharing epitopes labeled by the QE5 antibody may be present in the dense (lysosomal) bodies of plaque neurites. Indeed, nuclear remnants have been observed in plaque cores by one group (45) . Hirano bodies, rod-like intracellular structures frequently found in CA1 neurons in AD and immunopositive for several proteins including actin, actin-binding proteins, microtubule-associated proteins, and neurofilaments, were also labeled by QE5 (Fig. 8C) . However, immunopositivity for Nup62, Nup88, and NTF2 was not observed in neuritic plaques or Hirano bodies.
Antibodies against active caspase-3 variously labeled neuritic plaques, Hirano bodies, and granulovacuolar degeneration, depending on which antibody was used. Sparse neuritic plaques within the hippocampus exhibited patchy label by PAb CM1 (but not the Promega antibody) (Fig. 8B ). This observation, noted by others in senile plaques (25, 27, 46) , may reflect cleavage of amyloid precursor protein by active caspase-3.
In contrast, both active caspase-3 antibodies labeled Hirano bodies (Fig. 8D, E) . This finding is not surprising because these structures have been shown by Rossiter et al to contain fractin, an active caspase-3-generated fragment of actin (47) . Although the PAb CM1 antibody did not label Hirano bodies in their study, our finding of PAb CM1 immunopositivity agrees with that of other reports (26, 48) . Finally, our observation of active caspase-3 labeling of granulovacuolar degeneration (especially prominent with the Promega antibody) (Fig. 8F ) is similar to that previously reported (26, 39, 48) .
DISCUSSION
To our knowledge, this is the first study examining nucleoporins and related proteins in AD. Nucleoporin immunohistochemistry revealed a punctate label throughout the nuclear envelope, similar to that described in in vitro (11, 17) and rodent brain studies (34) (35) (36) (37) , outlining the nucleus in all cell types in AD and control cases. In particular, the crisp label provided by the Nup62 antibody may be useful in other studies related to nuclear envelope contour and integrity in neurons. In agreement with an earlier report examining NPC frequency, diameter, and distribution within CA1 neurons in rodents (35), we found no age-related changes in control cases derived from individuals ranging in age from 51 to 96 years.
Nuclear contour irregularity in neurons was significantly more common in AD than controls and tended to be more prominent in tangle-bearing cells, although regular nuclei occurred in neurons with and without NFT. Therefore, this nuclear change could not be solely attributed to the presence or absence of NFT. Moreover, we found no apparent difference in nucleoporin expression or distribution in AD versus controls, regardless of nuclear contour using antibodies labeling Nup62, Nup88, Nup153, and Nup214. Because certain processes such as apoptosis or cell-cycle changes cause disassembly of the NPC (15) (16) (17) (29) (30) (31) , it is conceivable that studies examining some of the many other nucleoporins within the NPC may evidence changes in neurodegenerative disease.
We did examine nuclear irregularity in AD neurons in relationship to apoptosis and found no association with either of 2 stages of apoptosis evidenced by the TUNEL method or active caspase-3 label. The extent of neuronal nuclear irregularity greatly exceeded the presence of either apoptotic marker. However, it is possible that nuclear irregularity coincides with earlier stages of the apoptotic pathway. For example, active caspase-9 (which activates caspase-3) as well as caspase-cleaved tau fragments have been observed in the hippocampus of AD brain (28) .
Similarly, because increased expression of cell-cycle regulators has been noted in AD (49, 50) and other neurodegenerative disorders (32) and cell-cycle change induces NPC reorganization, we examined nuclear irregularity in AD neurons in relationship to the cell-cycle marker, cyclin B1. However, we were unable to demonstrate any association between cyclin B1 immunopositivity and nuclear irregularity. The extent of nuclear irregularity far exceeded that of neuronal cyclin B1 immunopositivity.
In addition to examining NPC structural proteins, we investigated the distribution of NTF2, a critical NPC-associated protein essential for the active transport of large proteins through the NPC. We found juxtanuclear aggregates of NTF2 in a small subset of AD hippocampal neurons with and without neurofibrillary tangles. Although the significance of this finding is unclear, NTF2 aggregation may signify disruption of nucleocytoplasmic transport or overexpression of NTF2 contributing to neurofibrillary tangle formation and neuronal death. Ongoing nucleocytoplasmic transport requires maintenance of a RanGDP-RanGTP gradient across the nuclear envelope. NTF2 carries RanGDP into the nucleus (51) and moves among central transporter nucleoporins that contain FxFG repeats, including Nup62 (44) . Binding of NTF2 to the FxFG repeat nucleoporins is essential for cell viability, although overexpression can be detrimental to cell function. For example, overexpression of NTF2 in vitro resulted in growth inhibition and reduced transport rate (52) .
In summary, we have examined the distribution of nucleoporins and NPC-associated proteins and their relationship to the neuropathologic changes in AD. Nucleoporin immunohistochemistry proved to be an excellent technique with which to outline nuclear contour by routine light and confocal microscopy. This label highlighted the significantly more common nuclear irregularity in AD, often seen in association with neurofibrillary tangles. An intriguing accumulation of NTF2 was observed in scattered CA1 neurons in AD, suggesting dysfunction of nucleocytoplasmic transport. These observations provide a framework for subsequent investigations of the nuclear pore complex and nucleocytoplasmic transport in AD.
